Highlights the importance of renoprotection through hemodynamic stability and congestion avoidance in HFrEF patients, noting that evidence for renoprotective drugs often comes from sub-analyses.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nobuhiko Joki (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: